BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17086735)

  • 1. CXC chemokine receptor 3 modulates bleomycin-induced pulmonary injury via involving inflammatory process.
    Gao JM; Lu B; Guo ZJ
    Chin Med Sci J; 2006 Sep; 21(3):152-6. PubMed ID: 17086735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
    Gao JM; Lu B
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of pulmonary fibrosis by chemokine receptor CXCR3.
    Jiang D; Liang J; Hodge J; Lu B; Zhu Z; Yu S; Fan J; Gao Y; Yin Z; Homer R; Gerard C; Noble PW
    J Clin Invest; 2004 Jul; 114(2):291-9. PubMed ID: 15254596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Th1/Th2 commitment contributes to lung senescence in CXCR3-deficient mice.
    Huang J; Li Z; Yao X; Li Y; Reng X; Li J; Wang W; Gao J; Wang C; Tankersley CG; Huang K
    Exp Gerontol; 2013 Aug; 48(8):717-26. PubMed ID: 23583952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis.
    Horikawa M; Fujimoto M; Hasegawa M; Matsushita T; Hamaguchi Y; Kawasuji A; Matsushita Y; Fujita T; Ogawa F; Takehara K; Steeber DA; Sato S
    Am J Pathol; 2006 Sep; 169(3):740-9. PubMed ID: 16936251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
    Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
    J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin.
    Chen ES; Greenlee BM; Wills-Karp M; Moller DR
    Am J Respir Cell Mol Biol; 2001 May; 24(5):545-55. PubMed ID: 11350823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute pulmonary inflammation is inhibited in CXCR3 knockout mice after short-term cigarette smoke exposure.
    Nie L; Xiang RL; Liu Y; Zhou WX; Jiang L; Lu B; Pang BS; Cheng DY; Gao JM
    Acta Pharmacol Sin; 2008 Dec; 29(12):1432-9. PubMed ID: 19026162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis.
    Sakamoto H; Zhao LH; Jain F; Kradin R
    Exp Mol Pathol; 2002 Feb; 72(1):1-9. PubMed ID: 11784117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine receptor CXCR3 is important for lung tissue damage and airway remodeling induced by short-term exposure to cigarette smoking in mice.
    Nie L; Liu ZJ; Zhou WX; Xiang RL; Xiao Y; Lu B; Pang BS; Gao JM
    Acta Pharmacol Sin; 2010 Apr; 31(4):436-42. PubMed ID: 20208554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
    Russo RC; Guabiraba R; Garcia CC; Barcelos LS; RoffĂȘ E; Souza AL; Amaral FA; Cisalpino D; Cassali GD; Doni A; Bertini R; Teixeira MM
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):410-21. PubMed ID: 18836137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice.
    Saito F; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Ogawa Y; Yamada W; Shiraishi Y; Hasegawa N; Fujishima S; Takano H; Ishizaka A
    Am J Respir Cell Mol Biol; 2008 May; 38(5):566-71. PubMed ID: 18096870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis.
    Pignatti P; Brunetti G; Moretto D; Yacoub MR; Fiori M; Balbi B; Balestrino A; Cervio G; Nava S; Moscato G
    Am J Respir Crit Care Med; 2006 Feb; 173(3):310-7. PubMed ID: 16239626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Allergic Pulmonary Inflammation in CXCR3Knockout Mice Sensitized and Challenged with House Dust Mite Protein.
    Liu Z; Chen H; Chen X; Gao J; Guo Z
    PLoS One; 2016; 11(10):e0162905. PubMed ID: 27727269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
    Fujimoto H; Gabazza EC; Taguchi O; Nishii Y; Nakahara H; Bruno NE; D'Alessandro-Gabazza CN; Kasper M; Yano Y; Nagashima M; Morser J; Broze GJ; Suzuki K; Adachi Y
    Am J Pathol; 2006 Apr; 168(4):1086-96. PubMed ID: 16565485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
    Cabrera S; Gaxiola M; Arreola JL; RamĂ­rez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
    Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions.
    Bochner BS; Hudson SA; Xiao HQ; Liu MC
    J Allergy Clin Immunol; 2003 Nov; 112(5):930-4. PubMed ID: 14610482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise Reduces Lung Fibrosis Involving Serotonin/Akt Signaling.
    Pereira PR; Oliveira-Junior MC; Mackenzie B; Chiovatto JE; Matos Y; Greiffo FR; Rigonato-Oliveira NC; Brugemman TR; Delle H; Idzko M; Albertini R; Ligeiro Oliveira AP; Damaceno-Rodrigues NR; Caldini EG; Fernandez IE; Castro-Faria-Neto HC; Dolhnikoff M; Eickelberg O; Vieira RP
    Med Sci Sports Exerc; 2016 Jul; 48(7):1276-84. PubMed ID: 26895395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.